18.09.2013 09:38
The national Commission for Technology and Innovation (CTI) supports a research consortium for drug development to combat antibiotic resistances with an overall budget of CHF 2.1 million. The consortium consists of BioVersys AG, Basel, the Zurich University of Applied Sciences (ZHAW), Wädenswil, the University of Applied Science North Western Switzerland (FHNW), Muttenz, and research groups of the Universities of Basel, Berne and Geneva.